Atovaquone exerts its anticancer effect by inhibiting Na+/K+-ATPase ion transport in canine cancer cells

Background and Aim: New anticancer drugs are being developed to avoid the toxicity and chemoresistance of the currently available drugs. The Food and Drug Administration-approved anti-malarial drug atovaquone is known to act as a selective oxidative phosphorylation inhibitor in the mitochondria by c...

Ausführliche Beschreibung

Bibliografische Detailangaben

1. Verfasser:	Yousef Alharbi
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Veterinary World 2023-06-01
Schriftenreihe:	Veterinary World
Schlagworte:	atovaquone electrophysiology na+/k+-atpase oxidative phosphorylation oxidative stress plumbagin
Online-Zugang:	https://www.veterinaryworld.org/Vol.16/June-2023/1.pdf
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!